The WHO commissioned Eric Chow (left) and Jason Ong (right) to review alternative methods of STI testing from molecular methods. |
As most STIs do not present with any symptoms, screening is critical for early detection and management to avoid the development of complications in the infected individuals and onward transmission to others. Testing for chlamydia and gonorrhoea using molecular methods is costly, prohibiting its widespread use globally. There is a possibility to reduce testing costs if pooling samples from the same individual is feasible.